EcoDrugPlus

Prostaglandin-Endoperoxide Synthase 2

Ensembl ID : ENSDLEG00000005058
Gene Symbol: PTGS2
3 Cross references
240 Possible Orthologues:

Proteasome 20s Subunit Alpha 1

Ensembl ID : ENSDLEG00000005746
Gene Symbol: PSMA1
3 Cross references
237 Possible Orthologues:

Proteasome 20s Subunit Alpha 2

Ensembl ID : ENSDLEG00000004285
Gene Symbol: PSMA2
3 Cross references
231 Possible Orthologues:

Proteasome 20s Subunit Alpha 3

Ensembl ID : ENSDLEG00000006602
Gene Symbol: PSMA3
1 Cross references
244 Possible Orthologues:

Proteasome 20s Subunit Alpha 4

Ensembl ID : ENSDLEG00000000329
Gene Symbol: PSMA4
3 Cross references
250 Possible Orthologues:

Proteasome 20s Subunit Alpha 5

Ensembl ID : ENSDLEG00000015012
Gene Symbol: PSMA5
3 Cross references
211 Possible Orthologues:

Proteasome 20s Subunit Alpha 6

Ensembl ID : ENSDLEG00000012355
Gene Symbol: PSMA6
3 Cross references
309 Possible Orthologues:

Proteasome 20s Subunit Alpha 7

Ensembl ID : ENSDLEG00000007179
Gene Symbol: PSMA7
3 Cross references
155 Possible Orthologues:

Proteasome 20s Subunit Alpha 8

Ensembl ID : ENSDLEG00000003904
Gene Symbol: PSMA8
1 Cross references
198 Possible Orthologues:

Proteasome 20s Subunit Beta 1

Ensembl ID : ENSDLEG00000010151
Gene Symbol: PSMB1
1 Cross references
217 Possible Orthologues:

Proteasome 20s Subunit Beta 10

Ensembl ID : ENSDLEG00000003004
Gene Symbol: PSMB10
1 Cross references
172 Possible Orthologues:

Proteasome 20s Subunit Beta 2

Ensembl ID : ENSDLEG00000020616
Gene Symbol: PSMB2
3 Cross references
221 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).